Скайризи - analogs
Components: Risankizumab |
|||||||||
Pharmgroups: Immunosuppressants |
|||||||||
Prices in pharmacies: — Instructions Скайризи | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . MAC-PAS plus ✘ (incl) Treonyl-glutamyl-lysyl-lysyl-glutamyl-arginyl-arginyl-glutamyl-treonyl-valyl-glutamyl-arginyl-glutamyl-lysyl-glutamate ✘ (incl) Эвиталия. Комплекс сухих микроорганизмов пробиотиков ✘ (incl) Актиммун поливитамин ✘ (incl) Стомафлор ✘ (incl) Riluzole ✘ (incl) Ионоплазм ✘ (incl) Бисопролол+Гидрохлоротиазид Канон ✘ (incl) Vinisol ✘ (incl) Пустырник Форте Эвалар ✘ (incl) Цито Геликс ✘ (incl) Abciximab ✘ (incl) Xantinol nicotinate ✘ (incl) Rivaroxaban ✘ (incl) Vitazenova ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 40% 10.7-10.9€ Ralef Dangerous 🔍 [Leflunomide]
- 32% — ИЛСИРА Negative 🔍 [Levilimab]
- 30% 219.8€ Efleira neutral [Netakimab]
- 29% 1699.3€ Stelara Negative 🔍 [Ustekinumab]
- 28% — Lefomide Dangerous 🔍 [Leflunomide]
- 28% 18.9-19.6€ Leflaid Dangerous 🔍 [Leflunomide]
- 28% 41.7-42.1€ Thymodepressin Positive 🔍 [Gamma-D-glutamyl-L-tryptophan]
- 28% — Tauredon Negative 🔍 [Sodium aurothiomalate]
- 28% — Ранвэк Negative 🔍 [Upadacitinib]
- 26% 8.6-10.2€ Ehlafra Dangerous 🔍 [Leflunomide]
- 26% — Арресто Dangerous 🔍 [Leflunomide]
- 26% 6.9-8.6€ Leflunomide Canon Dangerous 🔍 [Leflunomide]
- 26% 478.2€ Артлегиа Negative 🔍 [Olokizumab]
- 26% 649.6€ Kevzara Negative 🔍 [Sarilumab]
- 26% — Desuric neutral [Benzbromarone]
- 26% 8.2-9€ Leflunomide Dangerous 🔍 [Leflunomide]
- 25% 9.5-10.7€ Arava Dangerous 🔍 [Leflunomide]
- 25% — Тофацитиниба цитрат Negative 🔍 [Tofacitinib]
- 25% 397.6-981.8€ Jakvinus Negative 🔍 [Tofacitinib]
- 21% 94.1-402.3€ Enbrel Negative 🔍 [Etanercept]
- 21% 530€ Simponi Negative 🔍 [Golimumab]
- 21% — Эрелзи Negative 🔍 [Etanercept]
- 21% 194.8-385.8€ Этанерцепт ПСК Negative 🔍 [Etanercept]
- 20% — Bioline Arthritis neutral [Bryonia alba and more 7Cimicifuga racemosa, Rhus toxicodendron, Coffea cruda, Colchicum autumnale, Dulcamara, Apis mellifica, Rhododendron chrysanthum]
- 20% 1.6-3.2€ Comari tinctura neutral [Comari palustri rhizomatum tinctura]
- 20% 321.8€ Тофара Dangerous 🔍 [Tofacitinib and more 1Aspartame]
- 19% 1524.6€ Tremfya Negative 🔍 [Guselkumab]
- 18% 292.3€ Remicade Negative 🔍 [Infliximab]
- 18% 148.5€ Infliximab Negative 🔍 [Infliximab]
- 18% 150€ Фламмэгис Negative 🔍 [Infliximab]
- 17% — Algostasin neutral
- 17% — Zinaxin neutral
- 17% — Taltz Negative 🔍 [Ixekizumab]
- 17% 44.6-44.9€ Restasis Negative 🔍 [Ciclosporin]
- 17% 678.3-708.4€ Orensia Negative 🔍 [Abatacept]
- 17% — Ciclopren Negative 🔍 [Ciclosporin]
- 17% 2.9€ Cyclosporin Sandoz Negative 🔍 [Ciclosporin]
- 16% 5.3-6€ Sandimmun Negative 🔍 [Ciclosporin]
- 15% 400.9-455€ Cosentyx Negative 🔍 [Secukinumab]
- 15% 287.8-721.5€ Mabthera Negative 🔍 [Rituximab]
- 15% — Кинерет Negative 🔍 [Anakinra]
- 14% — Allomaron neutral [Allopurinol+Benzbromarone and more 2Allopurinol, Benzbromarone]
- 14% 490€ Humira Negative 🔍 [Adalimumab]
- 14% 6.7-36.5€ Equoral Negative 🔍 [Ciclosporin]
- 14% — Panimun Bioral Negative 🔍 [Ciclosporin]
- 14% — Cyclosporin Negative 🔍 [Ciclosporin]
- 14% 415-436.2€ Otezla Negative 🔍 [Apremilast]
- 14% — Икервис Negative 🔍 [Ciclosporin]
- 13% — Orgasporin Negative 🔍 [Ciclosporin]
- 13% 182.6€ Генолар Negative 🔍 [Omalizumab]
Learn more about the selection of analogues
- The drug has «Скайризи» no complete analogues; 51 analog by action, the most similar - Ralef (10.7-10.9€).
- Medical online service has selected the best substitutes for Скайризи based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Скайризи analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.